ArticleFrontiers in neuroscience2024

Clinically approved immunomodulators ameliorate behavioral changes in a mouse model of hereditary spastic paraplegia type 11.

Michaela Hörner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.